(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRANSFORM ONCOLOGY CARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRANSFORM ONCOLOGY CARE

ST13

US500000088673382

Class

35, 36, 44, 45

Filing

88673382

Registration

6521433

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

10/12/2021

Trademark type

Word

Nice classes

35, 36, 44, 45

Filing date

10/30/2019

Registration date

10/12/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/12/2021

Last transaction

10/12/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/01/2019

First use in commerce

11/01/2019

Drawing code

4

Owner type

03

Owner location

Woonsocket, RI, US

Examiner

HOLTZ, ALLISON

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CVS Pharmacy, Inc.

Representatives

Erich G. Rhynhart

Technical classification

Nice Classes

Class 35Class 36Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Specialty pharmaceutical distributorship servicesdistributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management servicesclinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; business administration of pharmacy reimbursement programs and services; Medical referrals; Managed care serviceselectronic processing of health care and pharmaceutical information; Business management in the field of clinical trialsproviding information management services

Class 36

Insurance claims administration for medical claims and pharmaceuticalsprocessing of insurance claims and payment data; pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; financial administration of pharmacy reimbursement programs and services

Class 44

Providing health servicespersonal health assessments and screenings; disease care management services; Medical services in the field of oncologyprior authorization servicestherapy and diagnostic servicestreatment support services; Nursing services; Therapeutic pharmaceutical servicesdispensing of pharmaceuticals and counseling on medicationsincorporating disease monitoring services and clinical reviews; pharmaceutical advice; disease management programs; Medical servicesproviding in-home and ambulatory infusion pharmacy servicesproviding oncology services

Class 45

Specialty care management servicesproviding case management services in the nature of coordinating medical care for persons with medical conditions requiring specialized care

Publications

History of USPTO decisions and trademark events.

31 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/07/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/04/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/26/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/24/2021

IUAF

USE AMENDMENT FILED

08/20/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/20/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/24/2021

EX2G

SOU EXTENSION 2 GRANTED

07/22/2021

EXT2

SOU EXTENSION 2 FILED

07/22/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/22/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/22/2021

EX1G

SOU EXTENSION 1 GRANTED

01/20/2021

EXT1

SOU EXTENSION 1 FILED

01/20/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/20/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/09/2020

PUBO

PUBLISHED FOR OPPOSITION

06/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/28/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/27/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/29/2019

GNRT

NON-FINAL ACTION E-MAILED

11/29/2019

CNRT

NON-FINAL ACTION WRITTEN

11/29/2019

DOCK

ASSIGNED TO EXAMINER

11/21/2019

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

11/08/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/02/2019

NWAP

NEW APPLICATION ENTERED

11/02/2019

Continuous trademark protection

Get notified about every new filing that threatens TRANSFORM ONCOLOGY CARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.